Illinois Sports Medicine and Orthopaedic Centers
- PRP Therapy
- Laser Therapy (LLLT)
- Arthritis Treatment
- Stem Cell Therapy
Glenview, IL
stem cell consult rooms in Glenview IL sit along Waukegan Rd / Glenview Rd medical corridor, Golf Rd drive-time suites, and I-94 North Shore offices more than spa calendars. Local stem cell therapy clinics pack cash-pay menus between primary-care referrals and drive-time longevity pitches aimed at metro and suburb patients alike. A neighboring suburb commute changes who books follow-up, not the dosing math. This hub is Glenview IL listings, not Wilmette or Northbrook paste.
Stem cell marketing is not one product. Autologous vs donor sourcing, tissue type, and processing claims all change what you buy. Ask for the written protocol, not a brochure slogan.
This hub lists Directory clinics for Glenview IL and stem cell therapy. Inclusion is not an endorsement. Listing order is not paid ranking. Regenerated.com is free for patients. Featured slots stay labeled; Verified means credential checks, not spend.
Ask source of cells, processing claims, imaging guidance, follow-up schedule, and what happens if symptoms do not match the brochure. Local freeways shape booking windows, not the underlying biology. Prefer plain risk talk and written consent. Use the national stem cell therapy Directory and Guide, then return here.
Before you trust badges and counts on this page, read How to read a Regenerated city hub and Featured vs Verified vs organic. Then return here for local listings.
Regulatory context
Illinois cellular therapy is governed by 21 CFR Part 1271. Section 361 covers minimally manipulated HCT/Ps used for homologous use without premarket approval. Section 351 covers products that are more than minimally manipulated, used non-homologously, or combined with another article, and these require an IND for clinical use or a BLA for marketing. Most stem cell, stromal vascular fraction, and exosome therapies marketed in Illinois for orthopedic, neurologic, and longevity indications are Section 351 biologics that lack FDA approval. Chicago's medical research density also includes legitimate IND-based trials at academic institutions.
The FDA has issued warning letters to Illinois clinics offering stem cell, exosome, and umbilical cord-derived therapies. The Illinois Department of Financial and Professional Regulation has disciplined physicians for unprofessional conduct related to regenerative medicine. The Illinois Attorney General has used the Consumer Fraud and Deceptive Business Practices Act to pursue clinics making unsupported clinical claims, including class-action partnerships with private plaintiffs. Chicago's market draws ongoing federal attention. No statewide injunction parallel to the California SVF case has been issued, but enforcement risk remains material.
Available here
Nationwide
Stem Cell Therapy clinics across the US